Megan Mcbride MPH

Megan McBride is Associate Director in the Research & Development Operations Innovation (RDOi) department for Janssen. Building on almost 20 years’ experience in global clinical operations through her work in industry, NGOs and public-private partnerships, Megan is committed to driving innovation to modernize the clinical trial process not only for Janssen and pharma but for our key partners: patients, investigators and clinical research site teams.

Since joining J&J in 2014, Megan is on a mission to implement novel and compelling ways to better engage with patients, investigators and site teams. To this end, she currently leads projects focused on data transparency and access for patients actively participating in trials with the goal of creating a global trial engagement platform and community to enhance the trial experience before, during and after the trial.

Her background in drug and vaccine R&D at Merck & Co, Inc, and as Head of Global Clinical Operations for the International AIDS Vaccine Initiative (IAVI) provided unique opportunities to work on first ever HIV vaccine trials in Africa, robust community and patient engagement programs including the GPP initiative, and as a member of the PD Forum with the Bill and Melinda Gates Foundation. Megan earned her MPH from the Johns Hopkins University Bloomberg School of Public Health.